ELEK+RIK Development USA
Let’s talk

Amgen

Amgen is one of the world’s leading biotechnology companies, dedicated to discovering, developing, and delivering innovative human therapeutics. With a strong focus on science and innovation, Amgen’s mission is to unlock the potential of biology for patients suffering from serious illnesses. As a global biopharmaceutical leader, Amgen invests heavily in research and development (R&D) to identify breakthrough therapies. To accelerate its scientific discovery process, Amgen explored the integration of artificial intelligence (AI) into its drug development pipeline.

Client Challenge

The pharmaceutical industry faces one of the most complex and resource-intensive innovation processes: drug discovery. Traditionally, identifying promising molecules for potential therapies requires years of manual research, testing, and trial-and-error experimentation.

 

Amgen sought to:

 

  • Integrate generative AI models into its R&D workflow.
  • Analyze large, complex biomedical datasets efficiently.
  • Predict optimal molecular structures for targeted therapies.
  • Suggest potential drug candidates with greater precision.
  • Ensure compliance with pharmaceutical industry regulations and ethical AI standards.
  • Shorten research timelines without compromising scientific rigor or safety.

     

The challenge was clear: transform a manual, time-intensive process into a data-driven, AI-enhanced system that delivers faster and more accurate results.

ELEK+RIK’s Role and Approach

ELEK+RIK partnered with Amgen to design and implement a custom AI platform tailored for pharmaceutical R&D. Our work focused on AI development, compliance, and analytics to ensure the solution met both scientific and industry standards.

Our approach included:

Bullet

AI Development

Built generative AI models capable of simulating and predicting molecular interactions.

Bullet

AI Data Analytics

Trained models on large-scale biomedical datasets for improved accuracy.

Bullet

AI Compliance

Ensured that AI-driven processes adhered to FDA, EMA, and industry guidelines for safety and transparency.

Bullet

AI Platform Integration

Embedded AI into Amgen’s existing R&D infrastructure for seamless adoption.

Bullet

Iterative Implementation

Collaborated closely with Amgen’s research teams to refine algorithms and align with scientific goals.

Key Platform Features

Generative AI Models

Predict new molecular structures with high therapeutic potential.

Data-Driven Recommendations

Analyze billions of data points to suggest promising drug candidates.

Molecule Design Acceleration

Automate complex design tasks that traditionally required years of manual work.

Integrated AI Compliance Layer

Built-in safeguards to align with pharmaceutical regulations.

Scalable AI Platform

Adaptable to multiple therapeutic areas and research pipelines.

Results & Impact

The integration of AI into Amgen’s R&D pipeline delivered measurable advancements:

 

  • Accelerated Research Timelines — Reduced molecule design and evaluation processes from years to months.
  • Improved Precision — Increased accuracy in predicting molecular viability and drug candidate success.
  • Enhanced Productivity — Freed researchers from repetitive tasks, allowing focus on higher-value scientific exploration.
  • Scalable Innovation — Platform adaptable for future research projects across multiple therapeutic categories.
  • Positioned Amgen as a Pioneer — Recognized as a leader in applying generative AI to pharmaceutical discovery.

Key Takeaways

This project highlights ELEK+RIK’s ability to:

1

Bullet

Deliver AI development for pharmaceutical research.

Bullet

2

Integrate generative AI models into regulated industries.

3

Bullet

Build compliant AI platforms that accelerate scientific innovation.

4

Bullet

Provide AI data analytics and implementation expertise for global enterprises.

Work With an AI Development Partner in Healthcare

Looking to leverage AI for drug discovery, healthcare analytics, or pharmaceutical research? ELEK+RIK specializes in AI platform development, compliance, and implementation that drive real innovation. Contact us today to explore how AI can accelerate your R&D pipeline.